IART tops Q4 EPS and revenue estimates despite margin pressure and a sales dip, as shares edge higher and 2026 guidance signals modest growth.

IART tops Q4 EPS and revenue estimates despite margin pressure and a sales dip, as shares edge higher and 2026 guidance signals modest growth.

Box beats Q4 earnings estimates with 17% EPS growth and a 9% revenue rise, expands margins and lifts shares despite a 12 month slump.

Box beats Q4 earnings estimates with 17% EPS growth and a 9% revenue rise, expands margins and lifts shares despite a 12 month slump.

WLDN tops Q4 estimates with strong energy demand and 23% annual revenue growth, but shares tumble 13% after hours despite an upbeat 2026 outlook.

WLDN tops Q4 estimates with strong energy demand and 23% annual revenue growth, but shares tumble 13% after hours despite an upbeat 2026 outlook.

GIL's EPS rises 16% but misses estimates as sales jump 31% on HanesBrands, while margins expand, and the 2026 outlook is set.

GIL's EPS rises 16% but misses estimates as sales jump 31% on HanesBrands, while margins expand, and the 2026 outlook is set.

Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.

Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.